<DOC>
	<DOCNO>NCT00206050</DOCNO>
	<brief_summary>This Phase IV study intend compare intragastric acid suppression oral esomeprazole ( NEXIUM ® Delayed-Release Capsules ) oral pantoprazole ( PROTONIX ® Delayed Release Tablets ) , subject continue require acid-suppressive therapy follow course intravenous ( iv ) pantoprazole ( PROTONIX ® I.V . Injection ) .</brief_summary>
	<brief_title>Study Intragastric pH Profile After 5 Days Pantoprazole 40 mg iv Followed Oral Esomeprazole 40 mg po Oral Pantoprazole 40 mg po</brief_title>
	<detailed_description />
	<mesh_term>Pantoprazole</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Provision inform consent . Males female age 18 70 year , inclusive . Male nonpregnant , nonlactating female healthy volunteer subject . Females must postmenopausal , surgically sterilize , use medically acceptable form birth control , determine investigator . Women childbearing potential must agree continue use acceptable form birth control throughout conduct study . Involvement plan conduct study ( applies AstraZeneca staff staff investigational site ) Previous enrollment randomization treatment present study . Received experimental drug use experimental device within 28 day preceeding screen visit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2011</verification_date>
</DOC>